drugset / Trial / NCT00521521

Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer

NCT00521521 ↗

Phase 2 Completed 86 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the efficacy of the concomitant combination of radiotherapy and docetaxel with or without cisplatin in terms of objective response rates (WHO criteria).

Timeline

Start
2001-07
Primary completion
2006-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified — —
Comparator Docetaxel Small molecule — —